Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
| Published date | 25 January 2021 |
| Citation | 86 FR 6917 |
| Record Number | 2021-01504 |
| Section | Notices |
| Court | International Trade Commission |
6917
Federal Register / Vol. 86, No. 14 / Monday, January 25, 2021 / Notices
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Wuhan Healthgen Biotechnology Corp.,
No. 666 Gaoxin Avenue, East Lake
High-Tech Development Zone,
Wuhan, China, 430075
ScienCell Research Laboratories, Inc.,
1610 Faraday Avenue, Carlsbad,
California 92008
Aspira Scientific, Inc., 521 Cottonwood
Drive, Suite 112, Milpitas, California
95035
eEnzyme LLC, 963 Featherstone Street,
Gaithersburg, Maryland 20879
(c) The Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street SW, Suite
401, Washington, DC 20436; and
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondent in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), as
amended in 85 FR 15798 (March 19,
2020), such responses will be
considered by the Commission if
received not later than 20 days after the
date of service by the complainant of the
complaint and the notice of
investigation. Extensions of time for
submitting responses to the complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of the respondent to file a
timely response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: January 15, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021–01439 Filed 1–22–21; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 701–TA–636 and 731–
TA–1470 (Final)]
Wood Mouldings and Millwork
Products From China; Revised
Schedule for the Subject
Investigations
AGENCY
: United States International
Trade Commission.
ACTION
: Notice.
DATES
: January 13, 2021.
FOR FURTHER INFORMATION CONTACT
:
Keysha Martinez (202–205–2136), Office
of Investigations, U.S. International
Trade Commission, 500 E Street SW,
Washington, DC 20436. Hearing-
impaired persons can obtain
information on this matter by contacting
the Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server (https://
www.usitc.gov). The public record for
these investigations may be viewed on
the Commission’s electronic docket
(EDIS) at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION
: On August
12, 2020, the Commission established a
schedule for the conduct of the final
phase of the subject investigations (85
FR 54593, September 2, 2020). In light
of the federal holiday on January 20,
2021, the Commission is revising the
final comments deadline to no later than
10 a.m., January 21, 2021.
For further information concerning
this proceeding, see the Commission’s
notice cited above and the
Commission’s Rules of Practice and
Procedure, part 201, subparts A through
E (19 CFR part 201), and part 207,
subparts A and C (19 CFR part 207).
Authority: These investigations are being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to § 207.21 of the Commission’s
rules.
By order of the Commission.
Issued: January 19, 2021.
William Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2021–01532 Filed 1–22–21; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
Notice of Receipt of Complaint;
Solicitation of Comments Relating to
the Public Interest
AGENCY
: U.S. International Trade
Commission.
ACTION
: Notice.
SUMMARY
: Notice is hereby given that
the U.S. International Trade
Commission has received a complaint
entitled Certain Cellular
Communications Infrastructure
Systems, Components Thereof, and
Products Containing Same, DN 3525;
the Commission is soliciting comments
on any public interest issues raised by
the complaint or complainant’s filing
pursuant to the Commission’s Rules of
Practice and Procedure.
FOR FURTHER INFORMATION CONTACT
: Lisa
R. Barton, Secretary to the Commission,
U.S. International Trade Commission,
500 E Street SW, Washington, DC
20436, telephone (202) 205–2000. The
public version of the complaint can be
accessed on the Commission’s
Electronic Document Information
System (EDIS) at https://edis.usitc.gov.
For help accessing EDIS, please email
EDIS3Help@usitc.gov.
General information concerning the
Commission may also be obtained by
accessing its internet server at United
States International Trade Commission
(USITC) at https://www.usitc.gov. The
public record for this investigation may
be viewed on the Commission’s
Electronic Document Information
System (EDIS) at https://edis.usitc.gov.
Hearing-impaired persons are advised
that information on this matter can be
obtained by contacting the
Commission’s TDD terminal on (202)
205–1810.
SUPPLEMENTARY INFORMATION
: The
Commission has received a complaint
and a submission pursuant to § 210.8(b)
of the Commission’s Rules of Practice
and Procedure filed on behalf of
Ericsson Inc. and Telefonaktiebolaget
LM Ericsson on January 15, 2021. The
complaint alleges violations of section
337 of the Tariff Act of 1930 (19 U.S.C.
1337) in the importation into the United
States, the sale for importation, and the
sale within the United States after
importation of certain cellular
communications infrastructure systems,
components thereof, and products
containing same. The complaint names
as respondents: Samsung Electronics
Co. Ltd. of Korea and Samsung
Electronics America, Inc. of Ridgefield
Park, NJ. The complainant requests that
the Commission issue a limited
VerDate Sep<11>2014 18:31 Jan 22, 2021 Jkt 253001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\25JAN1.SGM 25JAN1
jbell on DSKJLSW7X2PROD with NOTICES
6918
Federal Register / Vol. 86, No. 14 / Monday, January 25, 2021 / Notices
1
Handbook for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
2
All contract personnel will sign appropriate
nondisclosure agreements.
3
Electronic Document Information System
(EDIS): https://edis.usitc.gov.
exclusion order, a cease and desist order
and impose a bond upon respondents’
alleged infringing articles during the 60-
day Presidential review period pursuant
to 19 U.S.C. 1337(j).
Proposed respondents, other
interested parties, and members of the
public are invited to file comments on
any public interest issues raised by the
complaint or § 210.8(b) filing.
Comments should address whether
issuance of the relief specifically
requested by the complainant in this
investigation would affect the public
health and welfare in the United States,
competitive conditions in the United
States economy, the production of like
or directly competitive articles in the
United States, or United States
consumers.
In particular, the Commission is
interested in comments that:
(i) Explain how the articles
potentially subject to the requested
remedial orders are used in the United
States;
(ii) identify any public health, safety,
or welfare concerns in the United States
relating to the requested remedial
orders;
(iii) identify like or directly
competitive articles that complainant,
its licensees, or third parties make in the
United States which could replace the
subject articles if they were to be
excluded;
(iv) indicate whether complainant,
complainant’s licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to the requested
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the requested
remedial orders would impact United
States consumers.
Written submissions on the public
interest must be filed no later than by
close of business, eight calendar days
after the date of publication of this
notice in the Federal Register. There
will be further opportunities for
comment on the public interest after the
issuance of any final initial
determination in this investigation. Any
written submissions on other issues
must also be filed by no later than the
close of business, eight calendar days
after publication of this notice in the
Federal Register. Complainant may file
replies to any written submissions no
later than three calendar days after the
date on which any initial submissions
were due. Any submissions and replies
filed in response to this Notice are
limited to five (5) pages in length,
inclusive of attachments.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above. Submissions should refer
to the docket number (‘‘Docket No.
3525’’) in a prominent place on the
cover page and/or the first page. (See
Handbook for Electronic Filing
Procedures, Electronic Filing
Procedures
1
). Please note the
Secretary’s Office will accept only
electronic filings during this time.
Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov.) No in-person paper-
based filings or paper copies of any
electronic filings will be accepted until
further notice. Persons with questions
regarding filing should contact the
Secretary at EDIS3Help@usitc.gov.
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,
2
solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.
3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: January 19, 2021.
William Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2021–01504 Filed 1–22–21; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Inv. No. 337–TA–1239]
Certain Gabapentin Immunoassay Kits
and Test Strips, Components Thereof,
and Methods Therefor; Institution of
Investigation
AGENCY
: U.S. International Trade
Commission.
ACTION
: Notice.
SUMMARY
: Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on
December 2, 2020, under section 337 of
the Tariff Act of 1930, as amended, on
behalf of ARK Diagnostics, Inc. of
Fremont, California. A supplement to
the complaint was filed on December 2,
2020 and an amended complaint was
filed on December 23, 2020. The
complaint, as amended, alleges
violations of section 337 based upon the
importation into the United States, the
sale for importation, and the sale within
the United States after importation of
certain gabapentin immunoassay kits
and test strips, components thereof, and
methods therefor by reason of
infringement of certain claims of U.S.
Patent No. 8,828,665 (‘‘the ’665 patent’’)
and U.S. Patent No. 10,203,345 (‘‘the
’345 patent’’). The complaint further
alleges that an industry in the United
States exists as required by the
applicable Federal Statute. The
complainant requests that the
Commission institute an investigation
and, after the investigation, issue a
limited exclusion order and cease and
desist orders.
ADDRESSES
: The complaint, except for
any confidential information contained
therein, may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. For help
accessing EDIS, please email
EDIS3Help@usitc.gov. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at (202) 205–
2000. General information concerning
the Commission may also be obtained
VerDate Sep<11>2014 18:31 Jan 22, 2021 Jkt 253001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\25JAN1.SGM 25JAN1
jbell on DSKJLSW7X2PROD with NOTICES
